| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11033-020-05378-7 |
| P698 | PubMed publication ID | 32180084 |
| P50 | author | Petra Riedlova | Q90374338 |
| P2093 | author name string | B Hermanova | |
| J Janoutova | |||
| P2860 | cites work | BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African | Q27002334 |
| Genetics of breast cancer: a topic in evolution | Q35775223 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer. | Q36700472 | ||
| Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer | Q36915151 | ||
| Epidemiology and prognosis of breast cancer in young women | Q36963366 | ||
| Prevalence and impact of founder mutations in hereditary breast cancer in Latin America | Q37697803 | ||
| Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal | Q37734261 | ||
| Beyond BRCA: new hereditary breast cancer susceptibility genes | Q38281676 | ||
| Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis. | Q38281709 | ||
| Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers | Q38717239 | ||
| Differences in incidence, mortality and survival of breast cancer by regions and countries in Asia and contributing factors | Q39020291 | ||
| A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients | Q40700340 | ||
| Breast cancer risk factor evaluation in a Western Himalayan state: A case-control study and comparison with the Western World | Q42364829 | ||
| Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations | Q44602623 | ||
| Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. | Q44946113 | ||
| BRCA1 and BRCA2 mutations in women from Shanghai China | Q47197575 | ||
| BRCA1 and BRCA2 germline variants in breast cancer patients from the Republic of Macedonia. | Q48238594 | ||
| Subtypes of Benign Breast Disease as a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis Protocol. | Q49338759 | ||
| Prevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine. | Q50849096 | ||
| Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations. | Q50913863 | ||
| Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2. | Q51003387 | ||
| A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. | Q51192784 | ||
| Epidemiological characteristics of and risk factors for breast cancer in the world | Q64058041 | ||
| [PALB2 as Another Candidate Gene for Genetic Testing in Patients with Hereditary Breast Cancer in Czech Republic] | Q64389994 | ||
| Prevalence of BRCA1 and BRCA2 gene mutations in Chinese patients with high-risk breast cancer. | Q64951000 | ||
| Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland | Q73734735 | ||
| Hereditary ovarian cancer | Q81701223 | ||
| Evaluating BRCA mutation risk predictive models in a Chinese cohort in Taiwan | Q91903776 | ||
| [Hereditary breast cancer: genetic etiology and current possibilities of prevention and surgical treatment] | Q95540853 | ||
| P921 | main subject | Czech Republic | Q213 |
| ovarian cancer | Q172341 | ||
| P577 | publication date | 2020-03-16 | |
| P1433 | published in | Molecular Biology Reports | Q15752755 |
| P1476 | title | Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic |
Search more.